ACCELERON PHARMA INC Insider Trading for January 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACCELERON PHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ACCELERON PHARMA INC for January 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 17 2018 | XLRN | ACCELERON PHARMA I ... | Rovaldi Christopher | SVP, Program Mgmt a ... | Option Exercise | M | 24.11 | 11,000 | 265,210 | 12,000 | |
| Jan 17 2018 | XLRN | ACCELERON PHARMA I ... | Rovaldi Christopher | SVP, Program Mgmt a ... | Sell | S | 45.00 | 11,000 | 495,000 | 24,701 | 35.7 K to 24.7 K (-30.81 %) |
| Jan 17 2018 | XLRN | ACCELERON PHARMA I ... | Rovaldi Christopher | SVP, Program Mgmt a ... | Buy | M | 24.11 | 11,000 | 265,210 | 35,701 | 24.7 K to 35.7 K (+44.53 %) |
| Jan 04 2018 | XLRN | ACCELERON PHARMA I ... | Rovaldi Christopher | SVP, Program Mgmt a ... | Sell | S | 42.45 | 833 | 35,361 | 24,701 | 25.5 K to 24.7 K (-3.26 %) |
| Jan 04 2018 | XLRN | ACCELERON PHARMA I ... | Rovaldi Christopher | SVP, Program Mgmt a ... | Sell | S | 42.41 | 1,433 | 60,774 | 25,534 | 27 K to 25.5 K (-5.31 %) |
| Jan 04 2018 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | SVP & Chief Scienti ... | Sell | S | 42.41 | 4,300 | 182,363 | 92,675 | 97 K to 92.7 K (-4.43 %) |
| Jan 04 2018 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP, Corp. Dev., GC ... | Sell | S | 42.42 | 4,333 | 183,806 | 52,977 | 57.3 K to 53 K (-7.56 %) |
| Jan 04 2018 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 5.28 | 6,250 | 33,000 | 0 | |
| Jan 04 2018 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 6,251 | 24,254 | 0 | |
| Jan 04 2018 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 43.84 | 200 | 8,768 | 42,801 | 43 K to 42.8 K (-0.47 %) |
| Jan 04 2018 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 43.00 | 14,800 | 636,400 | 43,001 | 57.8 K to 43 K (-25.61 %) |
| Jan 04 2018 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 5.28 | 6,250 | 33,000 | 57,801 | 51.6 K to 57.8 K (+12.12 %) |
| Jan 04 2018 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 6,251 | 24,254 | 51,551 | 45.3 K to 51.6 K (+13.80 %) |
| Jan 04 2018 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 42.42 | 4,000 | 169,680 | 45,300 | 49.3 K to 45.3 K (-8.11 %) |
| Jan 04 2018 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 43.33 | 2,033 | 88,090 | 73,367 | 75.4 K to 73.4 K (-2.70 %) |
| Jan 04 2018 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 42.40 | 2,300 | 97,520 | 75,400 | 77.7 K to 75.4 K (-2.96 %) |
| Jan 04 2018 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 40.86 | 300 | 12,258 | 77,700 | 78 K to 77.7 K (-0.38 %) |